レポートナンバー 0000033020
湿疹治療薬の世界市場（2022-2026）
TechNavio
Global Eczema Therapeutics Market 2022-2026
発刊日
2022/08/24
言語英語
体裁PDF/120ページ
レポート概要
本レポートは、湿疹治療薬市場を分析します。
世界の湿疹治療薬市場は、予測期間中に約9.6 %のCAGRで推移し、2022年から2026年の間に43億6,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、強力なパイプラインによって牽引されています。
調査範囲
-
市場セグメント
➣ 適応症別
◇ アトピー性皮膚炎
◇ 接触性皮膚炎
◇ その他
➣ 地域別
◇ 北アメリカ
◇ ヨーロッパ
◇ アジア
◇ その他の地域
本調査では、今後数年間における湿疹治療薬市場の成長を促進する主要な理由の1つとして、事業戦略を挙げています。また、地政学的な不確実性や医療費の増加も、同市場の大きな需要につながると考えられます。
TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。
本レポートは以下の分野をカバーしています。
- 湿疹治療薬の市場規模
- 湿疹治療薬の市場予測
- 湿疹治療薬市場の業界分析
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な湿疹治療薬市場ベンダーの詳細な分析を提供します
-
調査企業
➣ AbbVie Inc.
➣ Alliance Pharma Plc
➣ Amneal Pharmaceuticals Inc.
➣ AstraZeneca Plc
➣ Bausch Health Co Inc.
➣ Bayer AG
➣ Cadila Pharmaceuticals Ltd.
➣ Eli Lilly and Co.
➣ Glenmark Pharmaceuticals Ltd.
➣ Incyte Corp.
➣ LEO Pharma AS
➣ Lupin Ltd.
➣ Mayo Foundation for Medical Education and Research
➣ Merck and Co. Inc.
➣ Novartis AG
➣ Pfizer Inc.
➣ Regeneron Pharmaceuticals Inc.
➣ Sanofi SA
➣ Teva Pharmaceutical Industries Ltd.
➣ Viatris Inc.
また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社について
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
レポート詳細
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Indication
5.1 Market segments
Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
5.2 Comparison by Indication
Exhibit 26: Chart on Comparison by Indication
Exhibit 27: Data Table on Comparison by Indication
5.3 Atopic dermatitis - Market size and forecast 2021-2026
Exhibit 28: Chart on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
5.4 Contact dermatitis - Market size and forecast 2021-2026
Exhibit 32: Chart on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Contact dermatitis - Year-over-year growth 2021-2026 (%)
5.5 Other indication - Market size and forecast 2021-2026
Exhibit 36: Chart on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Other indication - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Other indication - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Indication
Exhibit 40: Market opportunity by Indication ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 89: AbbVie Inc. - Overview
Exhibit 90: AbbVie Inc. - Product / Service
Exhibit 91: AbbVie Inc. - Key offerings
10.4 Alliance Pharma Plc
Exhibit 92: Alliance Pharma Plc - Overview
Exhibit 93: Alliance Pharma Plc - Business segments
Exhibit 94: Alliance Pharma Plc - Key offerings
Exhibit 95: Alliance Pharma Plc - Segment focus
10.5 Amneal Pharmaceuticals Inc.
Exhibit 96: Amneal Pharmaceuticals Inc. - Overview
Exhibit 97: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 98: Amneal Pharmaceuticals Inc. - Key news
Exhibit 99: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 100: Amneal Pharmaceuticals Inc. - Segment focus
10.6 AstraZeneca Plc
Exhibit 101: AstraZeneca Plc - Overview
Exhibit 102: AstraZeneca Plc - Product / Service
Exhibit 103: AstraZeneca Plc - Key news
Exhibit 104: AstraZeneca Plc - Key offerings
10.7 Bausch Health Co Inc
Exhibit 105: Bausch Health Co Inc - Overview
Exhibit 106: Bausch Health Co Inc - Business segments
Exhibit 107: Bausch Health Co Inc - Key news
Exhibit 108: Bausch Health Co Inc - Key offerings
Exhibit 109: Bausch Health Co Inc - Segment focus
10.8 Bayer AG
Exhibit 110: Bayer AG - Overview
Exhibit 111: Bayer AG - Business segments
Exhibit 112: Bayer AG - Key offerings
Exhibit 113: Bayer AG - Segment focus
10.9 Eli Lilly and Co.
Exhibit 114: Eli Lilly and Co. - Overview
Exhibit 115: Eli Lilly and Co. - Product / Service
Exhibit 116: Eli Lilly and Co. - Key offerings
10.10 LEO Pharma AS
Exhibit 117: LEO Pharma AS - Overview
Exhibit 118: LEO Pharma AS - Business segments
Exhibit 119: LEO Pharma AS - Key offerings
Exhibit 120: LEO Pharma AS - Segment focus
10.11 Pfizer Inc.
Exhibit 121: Pfizer Inc. - Overview
Exhibit 122: Pfizer Inc. - Product / Service
Exhibit 123: Pfizer Inc. - Key news
Exhibit 124: Pfizer Inc. - Key offerings
10.12 Sanofi SA
Exhibit 125: Sanofi SA - Overview
Exhibit 126: Sanofi SA - Business segments
Exhibit 127: Sanofi SA - Key news
Exhibit 128: Sanofi SA - Key offerings
Exhibit 129: Sanofi SA - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 130: Inclusions checklist
Exhibit 131: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 132: Currency conversion rates for US$
11.4 Research methodology
Exhibit 133: Research methodology
Exhibit 134: Validation techniques employed for market sizing
Exhibit 135: Information sources
11.5 List of abbreviations
Exhibit 136: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other indication - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other indication - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Indication ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Alliance Pharma Plc - Overview
Exhibits93: Alliance Pharma Plc - Business segments
Exhibits94: Alliance Pharma Plc - Key offerings
Exhibits95: Alliance Pharma Plc - Segment focus
Exhibits96: Amneal Pharmaceuticals Inc. - Overview
Exhibits97: Amneal Pharmaceuticals Inc. - Business segments
Exhibits98: Amneal Pharmaceuticals Inc. - Key news
Exhibits99: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits100: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits101: AstraZeneca Plc - Overview
Exhibits102: AstraZeneca Plc - Product / Service
Exhibits103: AstraZeneca Plc - Key news
Exhibits104: AstraZeneca Plc - Key offerings
Exhibits105: Bausch Health Co Inc - Overview
Exhibits106: Bausch Health Co Inc - Business segments
Exhibits107: Bausch Health Co Inc - Key news
Exhibits108: Bausch Health Co Inc - Key offerings
Exhibits109: Bausch Health Co Inc - Segment focus
Exhibits110: Bayer AG - Overview
Exhibits111: Bayer AG - Business segments
Exhibits112: Bayer AG - Key offerings
Exhibits113: Bayer AG - Segment focus
Exhibits114: Eli Lilly and Co. - Overview
Exhibits115: Eli Lilly and Co. - Product / Service
Exhibits116: Eli Lilly and Co. - Key offerings
Exhibits117: LEO Pharma AS - Overview
Exhibits118: LEO Pharma AS - Business segments
Exhibits119: LEO Pharma AS - Key offerings
Exhibits120: LEO Pharma AS - Segment focus
Exhibits121: Pfizer Inc. - Overview
Exhibits122: Pfizer Inc. - Product / Service
Exhibits123: Pfizer Inc. - Key news
Exhibits124: Pfizer Inc. - Key offerings
Exhibits125: Sanofi SA - Overview
Exhibits126: Sanofi SA - Business segments
Exhibits127: Sanofi SA - Key news
Exhibits128: Sanofi SA - Key offerings
Exhibits129: Sanofi SA - Segment focus
Exhibits130: Inclusions checklist
Exhibits131: Exclusions checklist
Exhibits132: Currency conversion rates for US$
Exhibits133: Research methodology
Exhibits134: Validation techniques employed for market sizing
Exhibits135: Information sources
Exhibits136: List of abbreviations
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Indication
5.1 Market segments
Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
5.2 Comparison by Indication
Exhibit 26: Chart on Comparison by Indication
Exhibit 27: Data Table on Comparison by Indication
5.3 Atopic dermatitis - Market size and forecast 2021-2026
Exhibit 28: Chart on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
5.4 Contact dermatitis - Market size and forecast 2021-2026
Exhibit 32: Chart on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Contact dermatitis - Year-over-year growth 2021-2026 (%)
5.5 Other indication - Market size and forecast 2021-2026
Exhibit 36: Chart on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Other indication - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Other indication - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Indication
Exhibit 40: Market opportunity by Indication ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 89: AbbVie Inc. - Overview
Exhibit 90: AbbVie Inc. - Product / Service
Exhibit 91: AbbVie Inc. - Key offerings
10.4 Alliance Pharma Plc
Exhibit 92: Alliance Pharma Plc - Overview
Exhibit 93: Alliance Pharma Plc - Business segments
Exhibit 94: Alliance Pharma Plc - Key offerings
Exhibit 95: Alliance Pharma Plc - Segment focus
10.5 Amneal Pharmaceuticals Inc.
Exhibit 96: Amneal Pharmaceuticals Inc. - Overview
Exhibit 97: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 98: Amneal Pharmaceuticals Inc. - Key news
Exhibit 99: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 100: Amneal Pharmaceuticals Inc. - Segment focus
10.6 AstraZeneca Plc
Exhibit 101: AstraZeneca Plc - Overview
Exhibit 102: AstraZeneca Plc - Product / Service
Exhibit 103: AstraZeneca Plc - Key news
Exhibit 104: AstraZeneca Plc - Key offerings
10.7 Bausch Health Co Inc
Exhibit 105: Bausch Health Co Inc - Overview
Exhibit 106: Bausch Health Co Inc - Business segments
Exhibit 107: Bausch Health Co Inc - Key news
Exhibit 108: Bausch Health Co Inc - Key offerings
Exhibit 109: Bausch Health Co Inc - Segment focus
10.8 Bayer AG
Exhibit 110: Bayer AG - Overview
Exhibit 111: Bayer AG - Business segments
Exhibit 112: Bayer AG - Key offerings
Exhibit 113: Bayer AG - Segment focus
10.9 Eli Lilly and Co.
Exhibit 114: Eli Lilly and Co. - Overview
Exhibit 115: Eli Lilly and Co. - Product / Service
Exhibit 116: Eli Lilly and Co. - Key offerings
10.10 LEO Pharma AS
Exhibit 117: LEO Pharma AS - Overview
Exhibit 118: LEO Pharma AS - Business segments
Exhibit 119: LEO Pharma AS - Key offerings
Exhibit 120: LEO Pharma AS - Segment focus
10.11 Pfizer Inc.
Exhibit 121: Pfizer Inc. - Overview
Exhibit 122: Pfizer Inc. - Product / Service
Exhibit 123: Pfizer Inc. - Key news
Exhibit 124: Pfizer Inc. - Key offerings
10.12 Sanofi SA
Exhibit 125: Sanofi SA - Overview
Exhibit 126: Sanofi SA - Business segments
Exhibit 127: Sanofi SA - Key news
Exhibit 128: Sanofi SA - Key offerings
Exhibit 129: Sanofi SA - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 130: Inclusions checklist
Exhibit 131: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 132: Currency conversion rates for US$
11.4 Research methodology
Exhibit 133: Research methodology
Exhibit 134: Validation techniques employed for market sizing
Exhibit 135: Information sources
11.5 List of abbreviations
Exhibit 136: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Atopic dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Atopic dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Contact dermatitis - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Contact dermatitis - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other indication - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other indication - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other indication - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Indication ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Alliance Pharma Plc - Overview
Exhibits93: Alliance Pharma Plc - Business segments
Exhibits94: Alliance Pharma Plc - Key offerings
Exhibits95: Alliance Pharma Plc - Segment focus
Exhibits96: Amneal Pharmaceuticals Inc. - Overview
Exhibits97: Amneal Pharmaceuticals Inc. - Business segments
Exhibits98: Amneal Pharmaceuticals Inc. - Key news
Exhibits99: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits100: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits101: AstraZeneca Plc - Overview
Exhibits102: AstraZeneca Plc - Product / Service
Exhibits103: AstraZeneca Plc - Key news
Exhibits104: AstraZeneca Plc - Key offerings
Exhibits105: Bausch Health Co Inc - Overview
Exhibits106: Bausch Health Co Inc - Business segments
Exhibits107: Bausch Health Co Inc - Key news
Exhibits108: Bausch Health Co Inc - Key offerings
Exhibits109: Bausch Health Co Inc - Segment focus
Exhibits110: Bayer AG - Overview
Exhibits111: Bayer AG - Business segments
Exhibits112: Bayer AG - Key offerings
Exhibits113: Bayer AG - Segment focus
Exhibits114: Eli Lilly and Co. - Overview
Exhibits115: Eli Lilly and Co. - Product / Service
Exhibits116: Eli Lilly and Co. - Key offerings
Exhibits117: LEO Pharma AS - Overview
Exhibits118: LEO Pharma AS - Business segments
Exhibits119: LEO Pharma AS - Key offerings
Exhibits120: LEO Pharma AS - Segment focus
Exhibits121: Pfizer Inc. - Overview
Exhibits122: Pfizer Inc. - Product / Service
Exhibits123: Pfizer Inc. - Key news
Exhibits124: Pfizer Inc. - Key offerings
Exhibits125: Sanofi SA - Overview
Exhibits126: Sanofi SA - Business segments
Exhibits127: Sanofi SA - Key news
Exhibits128: Sanofi SA - Key offerings
Exhibits129: Sanofi SA - Segment focus
Exhibits130: Inclusions checklist
Exhibits131: Exclusions checklist
Exhibits132: Currency conversion rates for US$
Exhibits133: Research methodology
Exhibits134: Validation techniques employed for market sizing
Exhibits135: Information sources
Exhibits136: List of abbreviations
